-
About
-
Education
-
Publications
-
Resources
-
Topics
Advertisement
Advertisement
ADVERTISEMENT
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement